Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,168 | -54,648 | -39,986 | -25,545 | -12,827 |
| Depreciation Amortization | 69 | 280 | 212 | 145 | 76 |
| Accounts payable and accrued liabilities | -34 | -1,083 | -7 | -732 | -293 |
| Other Working Capital | 4,137 | -4,266 | 532 | -65 | -660 |
| Other Operating Activity | -936 | 10,252 | 7,761 | 6,040 | 2,616 |
| Operating Cash Flow | $-6,932 | $-49,465 | $-31,488 | $-20,157 | $-11,088 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,276 | 4 | 5,402 | 18,056 | 11,353 |
| PPE Investments | N/A | -4 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 6,111 | 0 | 0 | 0 |
| Investing Cash Flow | $14,276 | $6,111 | $5,402 | $18,056 | $11,353 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | 1,385 | 120 | N/A | N/A |
| Other Financing Activity | 0 | 50,142 | 45,144 | 41,222 | 0 |
| Financing Cash Flow | $21 | $51,527 | $45,264 | $41,222 | $N/A |
| Exchange Rate Effect | -1 | 3 | -1 | N/A | -2 |
| Beginning Cash Position | 20,949 | 12,773 | 12,773 | 12,773 | 12,773 |
| End Cash Position | 28,313 | 20,949 | 31,950 | 51,894 | 13,036 |
| Net Cash Flow | $7,364 | $8,176 | $19,177 | $39,121 | $263 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,932 | -49,465 | -31,488 | -20,157 | -11,088 |
| Capital Expenditure | N/A | -4 | N/A | N/A | N/A |
| Free Cash Flow | -6,932 | -49,469 | -31,488 | -20,157 | -11,088 |